Original paper
Abstract A101: Nucleolin: A novel cell surface protein for neuroblastoma targeted therapy
Volume: 18, Issue: 12_Supplement, Pages: A101 - A101
Published: Dec 1, 2019
Abstract
Background: Neuroblastoma (NB) represents the most frequent and aggressive form of extracranial solid tumor of infants. Since the use of targeted therapies is severely limited by the lack of specific receptors, chemotherapy and radiotherapy remain the main treatment choices, which, nevertheless expose high-risk NB patients to unacceptable toxicity and to the development of drug resistance. Nucleolin (NCL), a multifunctional protein involved in...
Paper Details
Title
Abstract A101: Nucleolin: A novel cell surface protein for neuroblastoma targeted therapy
Published Date
Dec 1, 2019
Volume
18
Issue
12_Supplement
Pages
A101 - A101
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History